Luminoah, a medical technology company modernizing enteral nutrition, today announced a $25 million Series B financing led by Sandbox Clinical Ventures, with participation from the Blue Venture Fund, GV (Google Ventures), Sands Capital, Texas Medical Center Venture Fund, the CU Healthcare Innovation Fund, the American Gastroenterological Association GI Opportunity Fund, and existing investors.
News
Recent Stories
Houston digital health platform Koda lands strategic investment
Houston-based advance care planning platform Koda Health has added another investor to the lineup.The company secured a strategic investment for an undisclosed amount from UPMC Enterprises, the commercialization arm of the University of Pittsburgh Medical Center.
Medical Informatics Corp. Launches Sickbay Experience Demo Center at TMC Helix Park: Turning Signal into Action Through Tangible Collaboration
Medical Informatics Corp. (MIC)–a leader in vendor-neutral, virtual care and patient monitoring solutions–officially opened its new Sickbay Experience Demo Center at the Texas Medical Center (TMC) Helix Park. The interactive facility serves as a collaborative hub for health systems, clinical leaders, and life science innovators to experience how Sickbay (MIC’s signature, FDA-cleared platform) partners with
Texas Medical Center Venture Fund Announces Acquisition of CrossBridge Bio for $300 Million by Eli Lilly
The Texas Medical Center (TMC) Venture Fund, an early-stage healthcare investor, today announced the acquisition of its portfolio company, CrossBridge Bio, Inc., by Eli Lilly and Company for $300 million. The transaction reflects TMC Venture Fund’s role as lead investor in CrossBridge Bio and its ability to advance early-stage companies toward successful exit.
CrossBridge Bio Enters an Agreement to be Acquired by Eli Lilly to Advance Next-Generation Dual-Payload Antibody-Drug Conjugates
CrossBridge Bio, Inc., a pre-clinical biotechnology company pioneering the development of next-generation dual-payload antibody-drug conjugates (ADCs) today announced a definitive agreement to be acquired by Eli Lilly and Company (“Lilly”).
Top 50 Venture Capital Firms for Medical Device Startups
For medical device startups, funding is never far from mind. A device doesn’t make the leap from a design on paper to a patient’s bedside without the right financial backing.
Surf Therapeutics Announces Early Feasibility Study (EFS) To Advance Non-Invasive Approach to Neuromodulation for Rheumatoid Arthritis
Surf Therapeutics, a clinical-stage neuro-immunomodulation company developing non-invasive ultrasound therapy for chronic inflammatory diseases, is announcing the start of an Early Feasibility Study evaluating its investigational ultrasound device in people living with rheumatoid arthritis.